Breadcrumb

MEDIA_REFRESH_DATA

Media

U.S. News Room

Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19.
Read More

Education Can Help Save Lives: Join Us this Colorectal Cancer Awareness Month
Read More

World Cancer Day 2022: Kicking off a Three-year Inequities-Focused Campaign
Read More


Mosaic of Men and women raising hands

This Rare Disease Day, we hope you will join us in supporting the millions of people across the rare disease community by raising awareness of the resources, programs and support available at rarediseaseday.org.

Oncology R&D Leadership Update
Read More


Rutgers 2021 Fellowship Brochure
Download PDF

St. John's 2020 Post-Doctoral Fellowship Brochure
Download PDF



These Daiichi Sankyo images are intended for news media use only.


Locations

Office building located at 211 Mt. Airy Road, Basking Ridge, NJ

Daiichi Sankyo, Inc.
(Basking Ridge, NJ)

High resolution image
Low resolution image

Multi story office building in Tokyo

Daiichi Sankyo Co., Ltd.
(Tokyo, Japan)

High resolution image
Low resolution image

Multi story office building in Munich

Daiichi Sankyo Europe GmbH (Munich, Germany)

High resolution image
Low resolution image


 

People

White male in business suit

Ken Keller

President, US Commercial, Daiichi Sankyo, Inc.

Bio

High resolution image

Japanese man in business attire

Ken Takeshita, MD

Global Head of Research & Development,
Daiichi Sankyo

Bio

High resolution image

Japanese man in business attire

Koji Ogawa

Head, U.S. Corporate Division, Daiichi Sankyo, Inc.
Corporate Officer, Daiichi Sankyo Co., Ltd.

Bio

High resolution image


Products

Azor Product Logo

(amlodipine / olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity

Benicar Tablets Product Logo

(olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity

Benicar HCT Product Logo

(olmesartan medoxomil / hydrochlorothiazide)

See full prescribing information including boxed warning regarding fetal toxicity

Effient Product Logo

(prasugrel) tablets

See full prescribing information including boxed warning regarding bleeding risk, and medication guide.

Enhertu Product Logo

(fam-trastuzumab deruxtecan-nxki)

Savaysa Product Logo

(edoxaban) tablets

Tribenzor Product Logo

(olmesartan medoxomil / amlodipine / hydrocholorothiazide)

See full prescribing information including boxed warning regarding fetal toxicity

Turalio Product Logo

(Pexidartinib)

See full prescribing information, including boxed warning regarding liver toxicity and medication guide.


Resources to Help You Get Answers

Investor Relations:

DaiichiSankyoIR@daiichisankyo.co.jp
Or please click here to be redirected to our global IR site

 

Media Relations:

Oncology & RD Pipeline:

Jennifer Brennan
Office 908-992-6631
Mobile 908-900-3183
jbrennan2@dsi.com

 

Iron Deficiency Anemia (U.S.):

Matt Coppola
Office 908-992-7102
mcoppola@dsi.com

 

Corporate Communications (U.S.):

Kim Wix
Office 908-992-6633
Mobile 908-656-5447
kwix@dsi.com

 

You may also send an email to our general U.S. Public Affairs/Corporate Communications mailbox here: publicaffairs@dsi.com

To reach our communications team for Europe, please email: press@daiichi-sankyo.eu

To reach our communications team in Tokyo, please visit: https://www.daiichisankyo.com/media/

To reach Investor Relations, please email: DaiichiSankyoIR@daiichisankyo.co.jp